{
    "2020-04-10": [
        [
            {
                "time": "",
                "original_text": "案例说：制药企业的转型路径",
                "features": {
                    "keywords": [
                        "制药企业",
                        "转型路径"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "顾客流量激增超700%，老字号用了这个新招儿",
                "features": {
                    "keywords": [
                        "顾客流量",
                        "老字号",
                        "新招儿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "零售",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "禁野令并非一刀切，已有熊胆制剂用于新冠治疗，公司年营收15亿_凤凰网科技_凤凰网",
                "features": {
                    "keywords": [
                        "禁野令",
                        "熊胆制剂",
                        "新冠治疗",
                        "年营收"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "四家上市中药企业2019年实现营收破百亿",
                "features": {
                    "keywords": [
                        "上市中药企业",
                        "2019年",
                        "营收破百亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "社保基金去年四季度重仓股揭秘：19股社保基金持股比例超5%",
                "features": {
                    "keywords": [
                        "社保基金",
                        "重仓股",
                        "持股比例"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}